Duncan McHale
CIK 1738896 · Chief Medical Officer · last filed 2023-11-08
Duncan McHale is a Chief Medical Officer who has filed 12 SEC Form 4 insider transactions across 1 company since 2018. The most recent filing, for EVLO, was dated Nov 8, 2023. Across all open-market trades the lifetime net is +$5.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2 across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2
1
12
$5.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EVLO | Chief Medical Officer | 20,087 | $0.00 | $2 | $5.7K | 12 | 2023-11-08 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-11-08 | EVLO | Mixed | +3,397 | -$1.0K | EDGAR |
| 2023-11-03 | EVLO | Mixed | +5,646 | -$2.3K | EDGAR |
| 2023-09-13 | EVLO | Grant (A) | — | $0 | EDGAR |
| 2023-08-09 | EVLO | Mixed | +3,066 | -$32.7K | EDGAR |
| 2023-05-10 | EVLO | Sell (S) | −66,730 | -$8.4K | EDGAR |
| 2023-05-09 | EVLO | Exer (M) | +130,000 | $0 | EDGAR |
| 2023-02-09 | EVLO | Grant (A) | — | $0 | EDGAR |
| 2022-05-31 | EVLO | Buy (P) | +34,246 | $50.0K | EDGAR |
| 2022-01-21 | EVLO | Grant (A) | — | $0 | EDGAR |
| 2021-01-29 | EVLO | Grant (A) | — | $0 | EDGAR |